Recovery of spontaneous erectile function after nervesparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil

Results of a prospective, randomized trial

Francesco Montorsi, Giorgio Guazzoni, Luigi Ferini Strambi, Luigi F. Da Pozzo, Luciano Nava, Luigi Barbieri, Patrizio Rigatti, Giuliano Pizzini, Alberto Miani

Research output: Contribution to journalArticle

409 Citations (Scopus)

Abstract

Purpose: This study was aimed at assessing prospectively the effect of postoperative intracavernous injections of alprostadil on the recovery of spontaneous erectile function after nervesparing radical retropubic prostatectomy. Materials and Methods: A total of 30 potent patients with clinically localized prostate cancer (clinical stage B1 or B2, Gleason sum 7 or greater, prostatic specific antigen less than 20 ng./ml.) underwent nerve- sparing radical retropubic prostatectomy and was subsequently randomized to alprostadil injections 3 times per week for 12 weeks (group 1, 15 patients) or observation without any erectogenic treatment (group 2, 15 patients). Patients were assessed at the 6-month followup by sexual history, physical examination, color Doppler sonography of the cavernous arteries and polisomnographic recording of nocturnal erections. Results: In group 1, 12 patients (80%) completed the entire treatment schedule and were evaluated at the long-term followup. Eight patients in this group (67%) reported the recovery of spontaneous erection sufficient for satisfactory sexual intercourse, compared with 3 patients (20%) in group 2. The difference between the 2 groups was statistically significant (p

Original languageEnglish
Pages (from-to)1408-1410
Number of pages3
JournalJournal of Urology
Volume158
Issue number4
DOIs
Publication statusPublished - Oct 1997

Fingerprint

Alprostadil
Prostatectomy
Injections
Doppler Color Ultrasonography
Coitus
Physical Examination
Prostatic Neoplasms
Appointments and Schedules
Arteries
Observation
Antigens
Therapeutics

Keywords

  • Alprostadil
  • Penis
  • Prostate
  • Prostatectomy

ASJC Scopus subject areas

  • Urology

Cite this

Recovery of spontaneous erectile function after nervesparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil : Results of a prospective, randomized trial. / Montorsi, Francesco; Guazzoni, Giorgio; Strambi, Luigi Ferini; Da Pozzo, Luigi F.; Nava, Luciano; Barbieri, Luigi; Rigatti, Patrizio; Pizzini, Giuliano; Miani, Alberto.

In: Journal of Urology, Vol. 158, No. 4, 10.1997, p. 1408-1410.

Research output: Contribution to journalArticle

Montorsi, Francesco ; Guazzoni, Giorgio ; Strambi, Luigi Ferini ; Da Pozzo, Luigi F. ; Nava, Luciano ; Barbieri, Luigi ; Rigatti, Patrizio ; Pizzini, Giuliano ; Miani, Alberto. / Recovery of spontaneous erectile function after nervesparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil : Results of a prospective, randomized trial. In: Journal of Urology. 1997 ; Vol. 158, No. 4. pp. 1408-1410.
@article{403104c967f84be998607654baa8ec33,
title = "Recovery of spontaneous erectile function after nervesparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil: Results of a prospective, randomized trial",
abstract = "Purpose: This study was aimed at assessing prospectively the effect of postoperative intracavernous injections of alprostadil on the recovery of spontaneous erectile function after nervesparing radical retropubic prostatectomy. Materials and Methods: A total of 30 potent patients with clinically localized prostate cancer (clinical stage B1 or B2, Gleason sum 7 or greater, prostatic specific antigen less than 20 ng./ml.) underwent nerve- sparing radical retropubic prostatectomy and was subsequently randomized to alprostadil injections 3 times per week for 12 weeks (group 1, 15 patients) or observation without any erectogenic treatment (group 2, 15 patients). Patients were assessed at the 6-month followup by sexual history, physical examination, color Doppler sonography of the cavernous arteries and polisomnographic recording of nocturnal erections. Results: In group 1, 12 patients (80{\%}) completed the entire treatment schedule and were evaluated at the long-term followup. Eight patients in this group (67{\%}) reported the recovery of spontaneous erection sufficient for satisfactory sexual intercourse, compared with 3 patients (20{\%}) in group 2. The difference between the 2 groups was statistically significant (p",
keywords = "Alprostadil, Penis, Prostate, Prostatectomy",
author = "Francesco Montorsi and Giorgio Guazzoni and Strambi, {Luigi Ferini} and {Da Pozzo}, {Luigi F.} and Luciano Nava and Luigi Barbieri and Patrizio Rigatti and Giuliano Pizzini and Alberto Miani",
year = "1997",
month = "10",
doi = "10.1016/S0022-5347(01)64227-7",
language = "English",
volume = "158",
pages = "1408--1410",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Recovery of spontaneous erectile function after nervesparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil

T2 - Results of a prospective, randomized trial

AU - Montorsi, Francesco

AU - Guazzoni, Giorgio

AU - Strambi, Luigi Ferini

AU - Da Pozzo, Luigi F.

AU - Nava, Luciano

AU - Barbieri, Luigi

AU - Rigatti, Patrizio

AU - Pizzini, Giuliano

AU - Miani, Alberto

PY - 1997/10

Y1 - 1997/10

N2 - Purpose: This study was aimed at assessing prospectively the effect of postoperative intracavernous injections of alprostadil on the recovery of spontaneous erectile function after nervesparing radical retropubic prostatectomy. Materials and Methods: A total of 30 potent patients with clinically localized prostate cancer (clinical stage B1 or B2, Gleason sum 7 or greater, prostatic specific antigen less than 20 ng./ml.) underwent nerve- sparing radical retropubic prostatectomy and was subsequently randomized to alprostadil injections 3 times per week for 12 weeks (group 1, 15 patients) or observation without any erectogenic treatment (group 2, 15 patients). Patients were assessed at the 6-month followup by sexual history, physical examination, color Doppler sonography of the cavernous arteries and polisomnographic recording of nocturnal erections. Results: In group 1, 12 patients (80%) completed the entire treatment schedule and were evaluated at the long-term followup. Eight patients in this group (67%) reported the recovery of spontaneous erection sufficient for satisfactory sexual intercourse, compared with 3 patients (20%) in group 2. The difference between the 2 groups was statistically significant (p

AB - Purpose: This study was aimed at assessing prospectively the effect of postoperative intracavernous injections of alprostadil on the recovery of spontaneous erectile function after nervesparing radical retropubic prostatectomy. Materials and Methods: A total of 30 potent patients with clinically localized prostate cancer (clinical stage B1 or B2, Gleason sum 7 or greater, prostatic specific antigen less than 20 ng./ml.) underwent nerve- sparing radical retropubic prostatectomy and was subsequently randomized to alprostadil injections 3 times per week for 12 weeks (group 1, 15 patients) or observation without any erectogenic treatment (group 2, 15 patients). Patients were assessed at the 6-month followup by sexual history, physical examination, color Doppler sonography of the cavernous arteries and polisomnographic recording of nocturnal erections. Results: In group 1, 12 patients (80%) completed the entire treatment schedule and were evaluated at the long-term followup. Eight patients in this group (67%) reported the recovery of spontaneous erection sufficient for satisfactory sexual intercourse, compared with 3 patients (20%) in group 2. The difference between the 2 groups was statistically significant (p

KW - Alprostadil

KW - Penis

KW - Prostate

KW - Prostatectomy

UR - http://www.scopus.com/inward/record.url?scp=0030865724&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030865724&partnerID=8YFLogxK

U2 - 10.1016/S0022-5347(01)64227-7

DO - 10.1016/S0022-5347(01)64227-7

M3 - Article

VL - 158

SP - 1408

EP - 1410

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 4

ER -